Loading
Latest filing published 05 Jan 2022 for Virios Therapeutics, Inc., €26k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
This profile gathers the share dealings of David R. Keefer in Dogwood Therapeutics, Inc., where the filings describe the role as board member. In total, 2 filings cover trades dated from 28 January 2021 to 4 January 2022.
The open-market record is one-sided, with 1 purchase worth €26k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 1 option exercise. So far in 2022, the count stands at 1 purchase and no sales.
The record was last updated on 5 January 2022 with an open-market purchase (€26k) in Dogwood Therapeutics, Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration